Table 1.
Association between plasma miR-1229-3p level and clinicopathological characteristics in patients with GC.
| Variables | Plasma miR-1229-3p | ||||||
|---|---|---|---|---|---|---|---|
| n | High | Low | P-valuea | ||||
| Total | 60 | 22 | 38 | ||||
| Gender | Male | 39 | 14 | (64%) | 25 | (66%) | 0.866 |
| Female | 21 | 8 | (36%) | 13 | (34%) | ||
| Age | <65 | 26 | 7 | (32%) | 19 | (50%) | 0.171 |
| ≥65 | 34 | 15 | (68%) | 19 | (50%) | ||
| Tumor major axis (mm) | <50 | 29 | 7 | (32%) | 22 | (58%) | 0.064 |
| ≥50 | 31 | 15 | (68%) | 16 | (42%) | ||
| T-stage | T1/T2/T3 | 44 | 11 | (50%) | 33 | (87%) | 0.005 |
| T4 | 16 | 11 | (50%) | 5 | (13%) | ||
| N-stage | N0/N1/ N2 | 47 | 16 | (73%) | 31 | (82%) | 0.423 |
| N3 | 13 | 6 | (27%) | 7 | (18%) | ||
| pStage | II | 40 | 12 | (55%) | 28 | (74%) | 0.132 |
| III | 20 | 10 | (45%) | 10 | (26%) | ||
| Histopathological type | Differentiated | 21 | 7 | (32%) | 14 | (37%) | 0.693 |
| Undifferentiated | 39 | 15 | (68%) | 24 | (63%) | ||
| Lymphatic invasion | Negative | 14 | 4 | (18%) | 10 | (26%) | 0.542 |
| Positive | 46 | 18 | (8%) | 28 | (74%) | ||
| Venous invasion | Negative | 27 | 8 | (36%) | 19 | (50%) | 0.304 |
| Positive | 33 | 14 | (64%) | 19 | (50%) | ||
| Recurrence | Absent | 42 | 8 | (36%) | 34 | (89%) | <0.001 |
| Present | 18 | 14 | (64%) | 4 | (11%) | ||
Association between plasma miR-1229-3p level and clinicopathological characteristics in patients with GC. aChi-square or Fisher tests. NOTE: significant values are in bold.